CD38 Monoclonal Antibody Therapies for Multiple Myeloma
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology,Hematology
Reference114 articles.
1. Lendvai N, Hilden P, Devlin S, et al. A phase 2 single-center study of carfilzomib 56 mg/m2 with or without low-dose dexamethasone in relapsed or refractory multiple myeloma. Blood. In press.
2. Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial;San Miguel;Lancet Oncol,2013
3. Anti-CD20 antibody as consolidation therapy in a patient with primary plasma cell leukemia after high-dose therapy and autologous stem cell transplantation;Gemmel;Ann Hematol,2002
4. Short progression-free survival in myeloma patients receiving rituximab as maintenance therapy after autologous transplantation;Musto;Br J Haematol,2003
5. Rituximab treatment provides no clinical benefit in patients with pretreated advanced multiple myeloma;Zojer;Leuk Lymphoma,2006
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemia;Science Translational Medicine;2023-05-17
2. Relapsed/Refractory Multiple Myeloma: A Review of Available Therapies and Clinical Scenarios Encountered in Myeloma Relapse;Current Oncology;2023-02-15
3. Anti‐CD38 monoclonal antibody interference with blood compatibility testing: Differentiating isatuximab and daratumumab via functional epitope mapping;Transfusion;2022-10-14
4. Nanomedicines in B cell-targeting therapies;Acta Biomaterialia;2022-01
5. Leukocyte Membrane Enzymes Play the Cell Adhesion Game;Frontiers in Immunology;2021-11-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3